Drugs: Supply and Availability
Debate between Baroness Walmsley and Lord Evans of Rainow
Lord Evans of Rainow (Con)
The Government work closely with NICE on a multitude of new medicines and do a very good job of bringing them to the patients of need. If the noble Lord has any specific issues about any particular drugs, I can certainly look into that on his behalf.
Baroness Walmsley (LD)
My Lords, when a drug is in short supply and being replaced by an alternative, can the Minister say what guidance is given to GPs and pharmacists on how to ensure that the patient understands how to use the new product? This may be particularly important in the case of medical devices, such as those to control diabetes. I am thinking of pre-filled inulin pens, which all work in different ways and have different dosages. It is particularly important that the patient understands how to deliver it, when to deliver it and what the dosage should be.
Lord Evans of Rainow (Con)
The noble Baroness raises a very important point regarding medication for diabetes. She is absolutely right: when a patient is used to a medication, or indeed a device, it can be distressing and frustrating. We are aware of that. We want to assure noble Lords that the DHSC has well-established processes to manage supply issues, working with the supplier to resolve these issues as soon as possible. Where there is perhaps a shortage, it is very important that the patient gets training on the alternative device and that we get them back on to the device that they are familiar with.
Immunisation: Winter 2023-24
Debate between Baroness Walmsley and Lord Evans of Rainow(1 year, 9 months ago)
Lords ChamberRead Full debate Read Hansard Text
Lord Evans of Rainow (Con)
I thank my noble friend for that question. The Government are guided by the independent JCVI on vaccinations and immunisations. The intention of the vaccination offer to children is to increase the immunity of vaccinated individuals against severe Covid-19 in advance of a potential future wave. When formulating advice in relation to childhood immunisations, the JCVI has consistently maintained that the focus should be on the potential benefits and harms of vaccination to children and young people themselves; prevention of severe Covid-19 hospitalisations and deaths in children and young people is the primary aim.
Baroness Walmsley (LD)
My Lords, will the Minister say a little more about routine vaccination programmes? Although, as he says, in the UK childhood vaccination levels are quite high, they have been going down. Last year, 2021, none of the targets reached the WHO target of 95% for herd immunity. This trend of reducing numbers of children coming forward for routine programmes has gone on since 2012. What are the Government doing to reverse that trend, particularly in the light of the fact that it contributes to health inequalities?
Lord Evans of Rainow (Con)
I thank the noble Baroness for that excellent question. The Government are committed to child health, and, after clean water, vaccination is the most effective public health intervention for saving lives and promoting good health. The Government work with the NHS and the UK Health Security Agency to support accurate and up-to-date information on the benefits of vaccines to be available to parents, carers and patients. The NHS has recently concluded a call and recall campaign for parents or carers of anyone aged one to six who has missed their measles, mumps and rubella vaccination, or for anyone who missed it for any reason when invited to their GP, to catch up on their vaccination. GPs offer opportunistic vaccinations for anyone who visits the GP for any reason. There is a lot more we can do, such as using social media to appeal to younger people, but the Government are doing all we can.